We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Antimicrobial resistance in long-term care facilities

    Lindsay E Nicolle

    Department of Internal Medicine & Medical Microbiology, University of Manitoba, Health Sciences Centre, Room GG443, 820 Sherbrook Street, Winnipeg, MB, R3A 1R9, Canada.

    Published Online:https://doi.org/10.2217/fmb.11.145
    Free first page

    References

    • Richards C. Infections in residents of long-term care facilities: an agenda for research. Report of an expert panel. J. Am. Ger. Soc.50,570–576 (2002).
    • Smith PW, Bennett G, Bradley S et al. SHEA/APIC guideline: infection prevention and control in the long-term care facility. Infect. Cont. Hosp. Epidemiol.29,785–814 (2008).
    • Hughes C, Smith M, Tunney M. Infection control strategies for preventing the transmission of methicillin-resistant Staphylococcus aureus in nursing homes for older people. Cochrane Database of Syst. Rev.1,CD006354 (2008).
    • Faruno JP, Shurland SM, Zhan M et al. Comparison of methicillin-resistant Staphylococcus aureus acquisition among rehabilitation and nursing home residents. Infect. Cont. Hosp. Epidemiol.32,244–249 (2011).
    • Benenson S, Cohen MJ, Block C, Stern S, Weiss Y, Moses A. Vancomycin-resistant Enterococci in long-term care facilities. Infect. Cont. Hosp. Epidemiol.30,786–789 (2009).
    • Urban C, Mariano N, Bradford PA et al. Identification of CTX-M β-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities. Diag. Microbiol. Infect. Dis.66,402–406 (2010).
    • Alsterlund R, Carlsson B, Gezelius L, Haeggman S, Olsson-Liljequist B. Multi-resistant CTX-M-15 ESBL producing Escherichia coli in southern Sweden: description of an outbreak. Scan. J. Infect. Dis.41,410–415 (2009).
    • Rooney PJ, O’Leary MC, Loughrey AC et al. Nursing homes as a reservoir of extended spectrum β-lactamase producing ciprofloxacin-resistant Escherichia coli. J. Antimicrob. Chemother.64,635–641 (2009).
    • Won SY, Munoz-Price LS, Lolans K, Hota B, Weinstein RA, Hayden MK. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase producing Enterobacteriaceae. Clin. Infect. Dis.53,532–540 (2011).
    • 10  Sengstock DM, Thyagarajan R, Apalara J, Mira A, Chopra T, Kaye KS. Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin. Infect. Dis.50,1611–1616 (2010).
    • 11  O’Fallon E, Kandell R, Schreiber R, D’Agata EM. Acquisition of multidrug resistant Gram-negative bacteria: incidence and risk factors within a long-term care population. Infect. Cont. Hosp. Epidemiol.31,1148–1153 (2010).
    • 12  Ben-David D, Masarwa S, Navon-Venezia S et al. Carbapenem-resisant Klebsiella pneumoniae in post-acute-care facilities in Israel. Infect. Cont. Hosp. Epidemiol.32,845–853 (2011).
    • 13  Mody L, Bradley SF, Galecki A et al. Conceptual model for reducing infections and antimicrobial resistance in skilled nursing facilities: focusing on residents with indwelling devices. Clin. Infect. Dis.52,654–661 (2011).
    • 14  Pacio GA, Visintainer P, Magaire G, Wormster GP, Raffalli J, Montrecalvo MA. Natural history of colonization with vancomycin-resisatnt Enterococci, methicillin-resistant Staphylococcus aureus and resistant Gram-negative bacilli among long-term-care facility residents. Infect. Cont. Hosp. Epidemiol.24,246–250 (2003).
    • 15  Benoit SR, Nsa W, Richards CL et al. Factors associated with antimicrobial use in nursing homes: a multilevel model. J. Am. Ger. Soc.56,2039–2044 (2008).
    • 16  McClean P, Hughes C, Tunney M, Goosens H, Jans B. Antimicrobial prescribing in European nursing homes. J. Antmicrob. Chemother.66,1609–1616 (2011).
    • 17  Rao GG, Jeanes A, Russell H et al. Effectiveness of short-term, enhanced, infection control support in improving compliance with infection control guidelines and practice in nursing homes: a cluster randomized trial. Epidemiol. Infect.137,1465–1471 (2009).
    • 18  Baldwin NS, Gilpin DF, Tunney MM et al. Cluster randomized controlled trial of an infection control education and training intervention programme focusing on methicillin-resistant Staphylococcus aureus in nursing homes for older people. J. Hosp. Infect.76,36–41 (2010).
    • 19  High KP, Bradley SF, Gravenstein S et al. Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the infectious diseases society of America. Clin. Infect. Dis.48,149–171 (2009).
    • 20  Schooneveld T, Miller H, Sayles H, Watkins K, Smith PW. Survey of antimicrobial stewardship practices in Nebraska long-term care facilities. Infect. Cont. Hosp. Epidemiol.32,732–734 (2011).